Mar 2, 2026
CEO Anders Hultman and CFO Ellen Dittberner present the company's Q4'25 results - February 26, 2026
Q4 Interview: Redeye talks with CEO Anders Hultman
AroCell: Presentation of IDL Diagnostics Interim Report Q4 2025
Story so far
Earlier from IDL Diagnostics
- IDL Diagnostics (Q4 Review): Aims to broaden the sales model
- IDL Diagnostics AB (publ) Interim Report January 1st to December 31st, 2025
- IDL forms a joint venture with concile
- Strategy update: IDL Diagnostics
- IDL Diagnostics nomination committee for the AGM 2026
Later from IDL Diagnostics
- Anders Hultman will be stepping down as CEO of IDL Diagnostics
- The nomination committee's proposal for the board of IDL Diagnostics for the Annual General Meeting 2026
- IDL Diagnostics publishes the Annual Report for 2025
- IDL Diagnostics (publ) Interim Report January 1 – March 31, 2026
- IDL Diagnostics (Q1 Review): Strong start to 2026
Follow IDL Diagnostics into a list and get an email when it puts out news.
Follow IDL Diagnostics